These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 38996486)

  • 21. Pathogenesis of fibrosis in interstitial lung disease.
    Burgy O; Bellaye PS; Beltramo G; Goirand F; Bonniaud P
    Curr Opin Pulm Med; 2020 Sep; 26(5):429-435. PubMed ID: 32769673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry.
    Behr J; Bonella F; Günther A; Koschel D; Prasse A; Pittrow D; Klotsche J; Kreuter M;
    BMC Pulm Med; 2023 Feb; 23(1):64. PubMed ID: 36774483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
    Takei R; Matsuda T; Fukihara J; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Kondoh Y
    Front Med (Lausanne); 2023; 10():1067149. PubMed ID: 37457568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelation Between Fibroblasts and T Cells in Fibrosing Interstitial Lung Diseases.
    Lai Y; Wei X; Ye T; Hang L; Mou L; Su J
    Front Immunol; 2021; 12():747335. PubMed ID: 34804029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges.
    Kewalramani N; Machahua C; Poletti V; Cadranel J; Wells AU; Funke-Chambour M
    ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35747227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells.
    Kim JH; Podstawka J; Lou Y; Li L; Lee EKS; Divangahi M; Petri B; Jirik FR; Kelly MM; Yipp BG
    Nat Immunol; 2018 Feb; 19(2):192-201. PubMed ID: 29335647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?
    Patel S; Anzilotti C; Lucas M; Moore N; Chapel H
    Clin Exp Immunol; 2019 Nov; 198(2):212-223. PubMed ID: 31216049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diaphragmatic ultrasound findings correlate with dyspnea, exercise tolerance, health-related quality of life and lung function in patients with fibrotic interstitial lung disease.
    Santana PV; Cardenas LZ; de Albuquerque ALP; de Carvalho CRR; Caruso P
    BMC Pulm Med; 2019 Oct; 19(1):183. PubMed ID: 31638951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and immunity in IPF pathogenesis and treatment.
    Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
    Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome.
    Yousem SA; Gibson K; Kaminski N; Oddis CV; Ascherman DP
    Mod Pathol; 2010 Jun; 23(6):874-80. PubMed ID: 20228783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies.
    Magro CM; Waldman WJ; Knight DA; Allen JN; Nadasdy T; Frambach GE; Ross P; Marsh CB
    Hum Immunol; 2006; 67(4-5):284-97. PubMed ID: 16720208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway.
    Chen L; Tang RZ; Ruan J; Zhu XB; Yang Y
    Cell Cycle; 2019; 18(6-7):670-681. PubMed ID: 30829553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases.
    Edwards ST; Cruz AC; Donnelly S; Dazin PF; Schulman ES; Jones KD; Wolters PJ; Hoopes C; Dolganov GM; Fang KC
    J Pathol; 2005 Jul; 206(3):279-90. PubMed ID: 15887294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis.
    Nathan SD; Flaherty KR; Glassberg MK; Raghu G; Swigris J; Alvarez R; Ettinger N; Loyd J; Fernandes P; Gillies H; Kim B; Shah P; Lancaster L
    Chest; 2020 Aug; 158(2):637-645. PubMed ID: 32092321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging role of immune cells as drivers of pulmonary fibrosis.
    Mutsaers SE; Miles T; Prêle CM; Hoyne GF
    Pharmacol Ther; 2023 Dec; 252():108562. PubMed ID: 37952904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Intervention of Pulmonary Rehabilitation for Fibrotic Interstitial Lung Disease Is a Favorable Factor for Short-Term Improvement in Health-Related Quality of Life.
    Matsuo S; Okamoto M; Ikeuchi T; Zaizen Y; Inomoto A; Haraguchi R; Mori S; Sasaki R; Nouno T; Tanaka T; Hoshino T; Tsuda T
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis.
    Barbosa-Matos C; Borges-Pereira C; Libório-Ramos S; Fernandes R; Oliveira M; Mendes-Frias A; Silvestre R; Osório NS; Bastos HN; Santos RF; Guimarães S; Morais A; Mazzone M; Carvalho A; Cunha C; Costa S
    Respir Res; 2024 Jun; 25(1):257. PubMed ID: 38909206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiological diagnosis of fibrosing interstitial lung diseases: innovations and controversies.
    Carlicchi E; Harari S; Caminati A; Fughelli P; Zompatori M
    Int J Tuberc Lung Dis; 2020 Nov; 24(11):1156-1164. PubMed ID: 33172523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.